Glizavild-M Tablets

Glizavild-M offers a dual-action approach for managing Type 2 Diabetes Mellitus.

• Metformin improves insulin sensitivity and reduces hepatic glucose production.

• Gliclazide stimulates insulin secretion from the pancreas for better blood sugar control.

This combination is especially suitable for patients who require enhanced glucose regulation when monotherapy is insufficient.

Benefits:

• Fast & Sustained Sugar Control – Tackles both fasting and post-meal glucose levels.

• Dual Mechanism – Improves insulin action and stimulates insulin release.

• Reduced Risk of Hypoglycemia compared to older sulfonylureas.

• Trusted Choice for patients with moderate to high blood sugar levels.

Dosage:

One tablet once or twice daily with meals, or as directed by a healthcare professional.

Why Cardiever?

• Dedicated Cardio-Diabetic Expertise – Targeted product range.

• Quality You Can Trust – GMP & ISO certified manufacturing.

• Affordable, Accessible Care – Designed for long-term therapy.

• Preferred by Doctors – Proven clinical efficacy.